These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 7579720

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Adjuvant treatment for breast cancer in the elderly.
    Marchei P, Bianco V, Pignatelli E, Chiodini S, Santini D, Carico E, Marchei M, Vecchione A.
    Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150
    [Abstract] [Full Text] [Related]

  • 23. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
    Hillner BE.
    Cancer; 2004 Sep 15; 101(6):1311-22. PubMed ID: 15368322
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Treatment trends and factors associated with survival in T1aN0 and T1bN0 breast cancer patients.
    Kennedy T, Stewart AK, Bilimoria KY, Patel-Parekh L, Sener SF, Winchester DP.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2918-27. PubMed ID: 17638060
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G, Toi M, Miceli R, Vermeulen PB, Dittadi R, Biganzoli E, Morabito A, Fanelli M, Gatti C, Suzuki H, Tominaga T, Dirix LY, Gion M.
    Cancer J Sci Am; 1999 Oct 15; 5(2):101-11. PubMed ID: 10198732
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M, Schnürch HG, Bender HG, Goldhirsch A.
    Gynakologe; 1994 Apr 15; 27(2):49-63. PubMed ID: 8039743
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Disease related indicators for a proper choice of adjuvant treatments.
    Hayes DF.
    Breast; 2011 Oct 15; 20 Suppl 3():S162-4. PubMed ID: 22015287
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
    Cunnick G, Mokbel K.
    Int J Fertil Womens Med; 2005 Oct 15; 50(5 Pt 1):197-8. PubMed ID: 16468468
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial].
    Delozier T, Switsers O, Génot JY, Ollivier JM, Héry M, Namer M, Frenay M, Kerbrat P, Julien JP, Naja A, Janvier M, Macé-Lesec'h J.
    Bull Cancer; 1997 Jan 15; 84(1):25-30. PubMed ID: 9180855
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tumor angiogenesis in women with node-positive breast cancer.
    Folkman J.
    Cancer J Sci Am; 1995 Jan 15; 1(2):106-8. PubMed ID: 9166461
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.